These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 32150234)

  • 1. Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.
    Rao K; Malani PN
    JAMA; 2020 Apr; 323(14):1403-1404. PubMed ID: 32150234
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Guideline Highlights for the Hospitalist: Diagnosis and Management of Clostridium difficile in Adults.
    Parsons AS; Burger A; Pahwa AK
    J Hosp Med; 2020 Feb; 15(2):95-96. PubMed ID: 31532745
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis and Treatment of Clostridium difficile Infection.
    Gupta A; Cifu AS; Khanna S
    JAMA; 2018 Sep; 320(10):1031-1032. PubMed ID: 30178042
    [No Abstract]   [Full Text] [Related]  

  • 4. Fidaxomicin for the treatment of
    Skinner AM; Scardina T; Kociolek LK
    Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clostridioides difficile infection: various therapeutic approaches].
    Meuwly M; Chuard C
    Rev Med Suisse; 2022 Oct; 18(799):1896-1899. PubMed ID: 36226451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post-2021 Guidelines: Are Economic Barriers Finally Coming Down?
    Fang N; Ha D; Dong K; Leung T; Lee S; Holubar M; Meng L
    Clin Infect Dis; 2022 Aug; 75(3):519-521. PubMed ID: 34971358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.
    Cymbal M; Chatterjee A; Baggott B; Auron M
    Am J Med; 2024 Jul; 137(7):571-576. PubMed ID: 38508330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.
    Yamaguchi T; Konishi H; Aoki K; Ishii Y; Chono K; Tateda K
    J Infect Chemother; 2020 May; 26(5):483-491. PubMed ID: 32165071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
    Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
    Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
    Okumura H; Ueyama M; Shoji S; English M
    J Infect Chemother; 2020 Jun; 26(6):611-618. PubMed ID: 32165072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence.
    Zar FA
    Ann Intern Med; 2016 Jul; 165(2):JC4. PubMed ID: 27429316
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
    Skinner AM; Tan X; Sirbu BD; Danziger LH; Gerding DN; Johnson S
    Clin Infect Dis; 2021 Sep; 73(6):1107-1109. PubMed ID: 33714998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fidaxomicin versus vancomycin for Clostridioides difficile infection.
    Long B; Gottlieb M
    Acad Emerg Med; 2022 Dec; 29(12):1506-1507. PubMed ID: 36156832
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic Treatment for Clostridium difficile Infection in Adults.
    Wilson A
    Am J Nurs; 2018 Jul; 118(7):63. PubMed ID: 29957645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
    Okumura H; Fukushima A; Taieb V; Shoji S; English M
    J Infect Chemother; 2020 Jan; 26(1):43-50. PubMed ID: 31624029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile.
    Eyre DW; Babakhani F; Griffiths D; Seddon J; Del Ojo Elias C; Gorbach SL; Peto TE; Crook DW; Walker AS
    J Infect Dis; 2014 May; 209(9):1446-51. PubMed ID: 24218500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.
    Mikamo H; Tateda K; Yanagihara K; Kusachi S; Takesue Y; Miki T; Oizumi Y; Gamo K; Hashimoto A; Toyoshima J; Kato K
    J Infect Chemother; 2018 Sep; 24(9):744-752. PubMed ID: 29934056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Updated Czech guidelines for the treatment of patients with colitis due to Clostridioides difficile].
    Beneš J; Stebel R; Musil V; Krůtová M; Vejmelka J; Kohout P
    Klin Mikrobiol Infekc Lek; 2022 Sep; 28(3):77-94. PubMed ID: 36791303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
    N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.